Literature DB >> 23920373

In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: cell-based delivery system to target ocular surface diseases.

Elisabeth Stein1, Aleksandra Inic-Kanada, Sandra Belij, Jacqueline Montanaro, Nora Bintner, Simone Schlacher, Ulrike Beate Mayr, Werner Lubitz, Marijana Stojanovic, Hristo Najdenski, Talin Barisani-Asenbauer.   

Abstract

PURPOSE: For the successful topical administration of drugs or vaccines to treat ocular surface diseases, efficient and well-tolerated delivery systems/carriers for conjunctival delivery are crucial in the development of new treatment strategies. The present study investigated the efficiency of internalization of bacterial ghosts (BGs) produced from probiotic Escherichia coli Nissle 1917 (EcN) by human conjunctival epithelial (HCjE) cell line, the EcN BGs cytotoxicity for HCjE cells, and in vivo uptake of EcN BGs by conjunctival guinea pig epithelial cells.
METHODS: The uptake of EcN BGs by HCjE cells was analyzed by laser scanning microscopy and flow cytometry. Immunohistochemistry was used to localize the EcN BGs in the guinea pig conjunctival tissue. Cytotoxicity of EcN BGs on HCjE cells was evaluated by measurement of LDH.
RESULTS: Laser scanning microscopy and flow cytometry revealed that EcN BGs internalization by HCjE cells was time- and dose dependent. No cytotoxic effect on HCjE cells was observed after EcN BGs inoculation for 30 and 120 minutes, as well as 24 hours. In addition, the uptake of EcN BGs was detected in the conjunctival cells after in vivo administration of EcN BGs into the eye of the guinea pig.
CONCLUSIONS: The findings that EcN BGs are nontoxic and effectively internalized in vitro by human and in vivo by guinea pig conjunctival cells comprise an important contribution to the future use of BGs as a system for conjunctival delivery of drugs and vaccines, either to treat or prevent ocular surface diseases.

Entities:  

Keywords:  bacterial ghosts; drug delivery; guinea pig; human conjunctival cell line; ocular surface

Mesh:

Year:  2013        PMID: 23920373     DOI: 10.1167/iovs.13-12044

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

Review 1.  Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: Set the bugs to work?

Authors:  Fatemeh Farjadian; Mohsen Moghoofei; Soroush Mirkiani; Amir Ghasemi; Navid Rabiee; Shima Hadifar; Ali Beyzavi; Mahdi Karimi; Michael R Hamblin
Journal:  Biotechnol Adv       Date:  2018-02-28       Impact factor: 14.227

2.  Prodigiosin-Functionalized Probiotic Ghosts as a Bioinspired Combination Against Colorectal Cancer Cells.

Authors:  Nessrin Saleh; Hoda E Mahmoud; Hoda Eltaher; Maged Helmy; Labiba El-Khordagui; Ahmed A Hussein
Journal:  Probiotics Antimicrob Proteins       Date:  2022-08-28       Impact factor: 5.265

3.  Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis.

Authors:  Diana Groza; Sebastian Gehrig; Pavol Kudela; Martin Holcmann; Christine Pirker; Carina Dinhof; Hemma H Schueffl; Marek Sramko; Julia Hoebart; Fatih Alioglu; Michael Grusch; Manfred Ogris; Werner Lubitz; Bernhard K Keppler; Irena Pashkunova-Martic; Christian R Kowol; Maria Sibilia; Walter Berger; Petra Heffeter
Journal:  Oncoimmunology       Date:  2018-02-16       Impact factor: 8.110

Review 4.  Recent trends and advances in microbe-based drug delivery systems.

Authors:  Pravin Shende; Vasavi Basarkar
Journal:  Daru       Date:  2019-08-02       Impact factor: 3.117

Review 5.  Microorganisms with claimed probiotic properties: an overview of recent literature.

Authors:  Sabina Fijan
Journal:  Int J Environ Res Public Health       Date:  2014-05-05       Impact factor: 3.390

Review 6.  Bacterial ghosts as adjuvants: mechanisms and potential.

Authors:  Irshad A Hajam; Pervaiz A Dar; Gayeon Won; John Hwa Lee
Journal:  Vet Res       Date:  2017-06-24       Impact factor: 3.683

7.  Implications for Ophthalmic Formulations: Ocular Buffers Show Varied Cytotoxic Impact on Human Corneal-Limbal and Human Conjunctival Epithelial Cells.

Authors:  Nadine Schuerer; Elisabeth Stein; Aleksandra Inic-Kanada; Marion Pucher; Christine Hohenadl; Nora Bintner; Ehsan Ghasemian; Jacqueline Montanaro; Talin Barisani-Asenbauer
Journal:  Cornea       Date:  2017-06       Impact factor: 2.651

8.  Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface.

Authors:  Jacqueline Montanaro; Aleksandra Inic-Kanada; Angela Ladurner; Elisabeth Stein; Sandra Belij; Nora Bintner; Simone Schlacher; Nadine Schuerer; Ulrike Beate Mayr; Werner Lubitz; Nikolaus Leisch; Talin Barisani-Asenbauer
Journal:  Drug Des Devel Ther       Date:  2015-07-21       Impact factor: 4.162

9.  Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers.

Authors:  Aleksandra Inic-Kanada; Marijana Stojanovic; Simone Schlacher; Elisabeth Stein; Sandra Belij-Rammerstorfer; Emilija Marinkovic; Ivana Lukic; Jacqueline Montanaro; Nadine Schuerer; Nora Bintner; Vesna Kovacevic-Jovanovic; Ognjen Krnjaja; Ulrike Beate Mayr; Werner Lubitz; Talin Barisani-Asenbauer
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

10.  Effects of iota-carrageenan on ocular Chlamydia trachomatis infection in vitro and in vivo.

Authors:  Aleksandra Inic-Kanada; Elisabeth Stein; Marijana Stojanovic; Nadine Schuerer; Ehsan Ghasemian; Ana Filipovic; Emilija Marinkovic; Dejana Kosanovic; Talin Barisani-Asenbauer
Journal:  J Appl Phycol       Date:  2018-03-13       Impact factor: 3.215

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.